Author:
Privitera Michael,Richy Florent F.,Schabert Vernon F.
Subject
Behavioral Neuroscience,Neurology (clinical),Neurology
Reference50 articles.
1. XCOPRI® (cenobamate tablets), for oral use, CV [prescribing information]. Paramus, NJ: SK Life Science, Inc.; April, 2021.
2. Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures;Chung;Neurology,2020
3. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial;Krauss;Lancet Neurol,2020
4. Cenobamate for the treatment of focal seizures;Klein;US Neurol,2020
5. Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study;Sperling;Epilepsia,2020
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献